|Incyte to Present at Upcoming Investor Conference|
WILMINGTON, Del.--(BUSINESS WIRE)--Dec. 14, 2017--
Incyte Corporation (Nasdaq:INCY) announced today that it will present at
the 36th Annual J.P. Morgan Healthcare Conference on Monday,
January 8, 2018 at 1:30 pm (PST) in San Francisco.
The presentation and Q&A session will be webcast live and can be
accessed at www.incyte.com
in the Investors section under “Events and Presentations.” Investors
interested in listening to the live webcast should log on before the
start time in order to download any software required.
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical
company focused on the discovery, development and commercialization of
proprietary therapeutics. For additional information on Incyte, please
visit the Company's web site at www.incyte.com.
Follow @Incyte on Twitter at https://twitter.com/Incyte.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171214005001/en/
Source: Incyte Corporation
Catalina Loveman, +1
Booth, DPhil, +1 302-498-5914
The information in the press releases should be considered accurate only as of the date of the document or presentation. We disclaim any obligation to supplement or update the information in these documents or presentations.